Access cutting-edge septic shock treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access septic shock specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related septic shock treatment provided free
SHIPSS is a multi-institutional, prospective, controlled, randomized, double-blinded interventional trial that will examine the potential benefits and risks of adjunctive hydrocortisone prescribed for children with fluid and vasoactive-inotropic refractory septic shock. It is hypothesized that adjunctive hydrocortisone will significantly reduce the incidence of new and progressive organ dysfunction (primary outcome) and proportion of children with poor outcomes, defined as death or severely imp
Sponsor: Jerry Zimmerman
Check if you qualify for this septic shock clinical trial in San Francisco, CA
If you're searching for septic shock treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced septic shock specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.